NEWS
- NDC-1308 (MC1) Therapeutic for Seasonal Viral Influenza
- Differences Between NDC-1308 (MC1) and Dexamethasone
- Macrophage Inflammation In The Lungs
- ENDECE PRESENTS AT MICHAEL, MARCIA, and CHRISTA PARSEGHIAN SCIENTIFIC CONFERENCE FOR NPC RESEARCH | VIRTUAL SYMPOSIUMS
- ENDECE ANNOUNCES LEAD CLINICAL DEVELOPMENT CANDIDATE NDC-1308 (MC1) AS A THERAPEUTIC FOR SARS-CoV-2 AND COVID-19